Insulet | PODD - EPS Earnings Per Share


Insulet reported $1.42 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.42 1.2 1.02 May/06
FY2025Q4 Dec/2025 1.44 1.46 1.15 Feb/18
FY2025Q3 Sep/2025 1.24 1.14 0.90 Nov/06
FY2025Q2 Jun/2025 1.17 0.93 0.55 Aug/07
FY2025Q1 Mar/2025 1.02 0.77 0.23 May/08




Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Align Technology USD 2.58 0.71 Mar/2026
AtriCure USD 0 0.06 Mar/2026
Avanos Medical USD 0.11 0.18 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Becton, Dickinson and Co. USD 2.9 0.01 Mar/2026
Boston Scientific USD 0.8 0 Mar/2026
Cardinal Health USD 3.17 0.54 Mar/2026
Cooper Companies USD 1.04 0.38 Mar/2026
Dexcom USD 0.56 0.12 Mar/2026
Edwards Lifesciences USD 0.78 0.2 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Globus Medical USD 1.12 0.16 Mar/2026
ICU Medical USD 1.97 0.06 Mar/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.42 0.02 Mar/2026
Integra LifeSciences USD 0.54 0.29 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Masimo USD 1.07 1.25 Mar/2026
Medtronic USD 1.55 0.19 Mar/2026
Merit Medical Systems USD 0.86 0.18 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Solventum Corp USD 1.48 0.2 Mar/2026
Stryker USD 2.6 1.87 Mar/2026
Tandem Diabetes Care USD -0.3 0.29 Mar/2026
Teleflex USD 1.39 0.54 Mar/2026
West Pharmaceutical Services USD 2.13 0.09 Mar/2026
Zimmer Biomet Holdings USD 2.09 0.33 Mar/2026